News Network

EP. 1: European Commission Approval of Tucatinib in HER2+ BC
EP. 2: Favorable Safety Profile of Tucatinib for Metastatic HER2+ BC
EP. 3: Real-World Experience With Tucatinib in Germany and France
EP. 1: The First Oral GNRH Receptor Antagonist for Advanced Prostate Cancer
EP. 2: Advanced Prostate Cancer: New Findings From ASCO GU 2021
EP. 3: Risk Factors in Advanced Prostate Cancer
EP. 4: Advanced Prostate Cancer: Remaining Challenges
EP. 1: Treatment Approach for Stage II/III Resectable CRC
EP. 2: Role of ctDNA Testing/Monitoring in Early-Stage CRC
EP. 3: ctDNA Monitorization Length and Clinical Experience
EP. 4: ASCO GI 2021: Circulating Tumor DNA Analysis Data
EP. 5: ASCO GI 2021: MRD Detection With ctDNA From Assays
EP. 1: ASCO GU 2021 News: Dr. William Oh and Dr. Julie Graff
EP. 2: ASCO GU 2021 News: Drs. Bradley McGregor, David Braun, and
EP. 3: ASCO GU 2021 News: Dr. Petros Grivas and Dr. Arlene Siefker-Radtke
EP. 1: Treatment Considerations in mCRC
EP. 2: First-Line Options in mCRC
EP. 3: Optimizing First-Line Therapy in mCRC
EP. 4: Maintenance or Chemo-Free Interval in mCRC
EP. 5: Therapy After Progression in mCRC
EP. 6: Regorafenib in Third or Fourth Line for mCRC: Efficacy in the Re-DOS Trial
EP. 7: Regorafenib in Third or Fourth Line for mCRC: Safety in the Re-DOS Trial
EP. 8: TAS-102 in Third or Fourth Line for mCRC
EP. 9: Using Molecular Testing to Guide Treatment Selection in mCRC
EP. 10: Open Questions and Future Directions in mCRC
EP. 1: Treatment Advances in Metastatic Breast Cancer
EP. 2: Long-Term Disease Control in Metastatic Breast Cancer
EP. 3: Cytotoxic Chemotherapy for Metastatic Breast Cancer
EP. 4: Assessing Response to Chemotherapy in Metastatic Breast Cancer
EP. 5: Metastatic Breast Cancer: Chemotherapy Selection
EP. 6: Predicting Response to Chemotherapy in Metastatic Breast Cancer
EP. 7: Chemotherapy to Treat MBC: Drug Developments
EP. 8: Advantages of Oral Therapy for Metastatic Breast Cancer
EP. 9: At-Home Administration of Therapies to Treat MBC
EP. 10: Metastatic Breast Cancer Therapy: OPE
EP. 11: MBC Therapy: Tesetaxel/Capecitabine
EP. 12: Oral Therapies and Dose Reductions in MBC
EP. 13: Using Oral Therapies to Advance Care in MBC
x